AlphaCrest Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
AlphaCrest Capital Management's EW Position: Q4 2022 in Review
AlphaCrest Capital Management sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 42,944 shares — an estimated $3.55M sold.
AlphaCrest Capital Management first reported a position in EW in Q4 2018 and held it in 16 quarters. The position peaked at $4.3M in Q1 2021. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2022.
- AlphaCrest Capital Management reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
- AlphaCrest Capital Management sold 42,944 Edwards Lifesciences shares in Q4 2022, an estimated $3.55M.
- AlphaCrest Capital Management first reported a position in Edwards Lifesciences in Q4 2018 and held it in 16 quarters.
- AlphaCrest Capital Management's Edwards Lifesciences position peaked at $4.3M in Q1 2021.
- 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.
Based on AlphaCrest Capital Management's 13F filing for Q4 2022.